Home › Therapeutic areas › Immunology › Graves' Disease

Graves' Disease (3 companies)

Companies with an active program in Graves' Disease.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
IMVT Immunovant ImmunologyNeurology Rare 1 Phase 3 $6.87B 4
SEPN Septerna ImmunologyMetabolic+1 Rare 1 Phase 1 $1.90B 5
VRDN Viridian Therapeutics ImmunologyOphthalmology 2 Approved $3.41B 7